PSigma UK Growth Acc
|Bid Price||GBX 147.32||Offer Price||GBX 155.03|
|Mid Price||-||Day Change||GBX +-1.58 (0.01%)|
|Price Date||30 Aug 2013||Crown Rating|
|Shares Class||Inc.||Yield||1.15 %|
|Total Expense Ratio||1.96||Fund Size||900,000.00|
|Launch Date||06/10/2003||Standard Initial Charge (%)||5.25|
|Annual Management Charge (%)||1.50||Sector||IMA UK Equity Income|
|Min Investment (£)||1,000.00||Total Expense Ratio (%)||1.96|
|ISIN||GB00B23XW147||Min TopUp (£)||1,000.00|
To achieve long term capital growth. The Fund intends to invest primarily in UK companies but may also invest in other UK related companies. The Fund may also invest in other investments to the extent permitted by the FSA Rules as applicable from time to time.
Neil started his career in the industry at Royal Insurance in 1984 after graduating from Durham University with a degree in Economics and Mathematics. At Royal Insurance Neil passed his Society of Investment Analyst exams and, after three years as an analyst covering a variety of sectors, moved into fund management. In that role he managed a range of retail and institutional UK equity funds, including the Staff Pension Scheme, before moving to Prolific Asset Management in 1997. Neil was part of the team managing the award winning Prolific UK Blue Chip Trust, and ran the Prolific Convertible & Gilt Unit Trust. The team was also responsible for the in-house life fund UK equities worth over Â£1.5bn. Following Prolificâ€™s acquisition by Aberdeen Asset Management, Neil became Head of the Equity Income team, responsible for a product range with cÂ£800m assets and a track record stretching back for 25 years. In 2003, Neil joined Teather & Greenwood Investment Management running both equity income and growth retail funds and building further on his experience of managing non-FTSE100 investments. He joined PSigma Investment Management in May 2004, before joining PSigma Asset Management in January 2007 at launch, and is the manager of the PSigma UK Growth Fund.